News
MDBH
8.69
-0.69%
-0.06
MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q1 2024
MDB Capital Holdings reported earnings per share of -78 cents for the first quarter of 2024. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports. MDB capital Holdings just reported results for first quarter.
Investorplace · 4d ago
Financial Report Articles: Analysis and Insights
Press release · 4d ago
Weekly Report: what happened at MDBH last week (0506-0510)?
Weekly Report · 4d ago
Invizyne Names Michael Heltzen as CEO
Invizyne Technologies named Michael Heltzen as its chief executive ahead of a planned spin-off. The company filed in February for an initial public offering. Invizyne has previously served as CEO of Cardea Bio and Nanosens Innovations. The firm has applied to list its shares on the Nasdaq.
Dow Jones · 05/07 18:15
*Invizyne Technologies Names Michael Heltzen as CEO
Dow Jones · 05/07 17:55
*Invizyne Technologies Names Michael Heltzen Appointed as CEO
Dow Jones · 05/07 15:52
Press Release: Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
Invizyne Technologies Expands Leadership Team ahead of Proposed Offering and Listing on Nasdaq. Michael Heltzen appointed as CEO bringing 20 years of global commercial experience. Invizyne is a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals.
Dow Jones · 05/07 15:50
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
Invizyne Technologies, Inc. Is a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals. Michael Heltzen has been appointed as CEO of Invizyne. The company is based in California.
Barchart · 05/07 10:50
Weekly Report: what happened at MDBH last week (0429-0503)?
Weekly Report · 05/06 12:50
Weekly Report: what happened at MDBH last week (0422-0426)?
Weekly Report · 04/29 12:58
Weekly Report: what happened at MDBH last week (0415-0419)?
Weekly Report · 04/22 12:39
MDB CAPITAL HOLDINGS YEAR-END UPDATE
Reuters · 04/17 20:05
Weekly Report: what happened at MDBH last week (0408-0412)?
Weekly Report · 04/15 12:29
MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time
MDB Capital Holdings, LLC plans to host a Zoom webinar on April 17, 2024 to discuss its results for the fourth quarter and full fiscal year ended December 31, 2023. The company is a public venture platform with the objective of growing the public venture marketplace.
Barchart · 04/11 15:05
Weekly Report: what happened at MDBH last week (0401-0405)?
Weekly Report · 04/08 12:36
MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q4 2023
MDB Capital Holdings reported earnings per share of -80 cents for the fourth quarter of 2023. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports. MDB capital Holdings just reported results for fourth quarter.
Investorplace · 04/02 11:53
Weekly Report: what happened at MDBH last week (0325-0329)?
Weekly Report · 04/01 12:31
Weekly Report: what happened at MDBH last week (0318-0322)?
Weekly Report · 03/25 12:35
Weekly Report: what happened at MDBH last week (0311-0315)?
Weekly Report · 03/18 12:34
Weekly Report: what happened at MDBH last week (0304-0308)?
Weekly Report · 03/11 12:27
More
Webull provides a variety of real-time MDBH stock news. You can receive the latest news about MDB Capital Holdings LLC-A through multiple platforms. This information may help you make smarter investment decisions.
About MDBH
MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, Invizyne Technologies, Inc. (Invizyne). The Company's segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment has one subsidiary, Invizyne. Invizyne is a research and development stage synthetic biology company. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.